Immunoglobulin recognition of fecal bacteria in stunted and non-stunted children: findings from the Afribiota study.


Journal

Microbiome
ISSN: 2049-2618
Titre abrégé: Microbiome
Pays: England
ID NLM: 101615147

Informations de publication

Date de publication:
27 07 2020
Historique:
received: 22 05 2020
accepted: 05 07 2020
entrez: 29 7 2020
pubmed: 29 7 2020
medline: 31 3 2021
Statut: epublish

Résumé

Child undernutrition is a global health issue that is associated with poor sanitation and an altered intestinal microbiota. Immunoglobulin (Ig) A mediates host-microbial homeostasis in the intestine, and acutely undernourished children have been shown to have altered IgA recognition of the fecal microbiota. We sought to determine whether chronic undernutrition (stunting) or intestinal inflammation were associated with antibody recognition of the microbiota using two geographically distinct populations from the Afribiota project. Fecal bacteria from 200 children between 2 and 5 years old in Antananarivo, Madagascar, and Bangui, Central African Republic (CAR), were sorted into IgA-positive (IgA+) and IgA-negative (IgA-) populations by flow cytometry and subsequently characterized by 16S rRNA gene sequencing to determine IgA-bacterial targeting. We additionally measured IgG+ fecal bacteria by flow cytometry in a subset of 75 children. Stunted children (height-for-age z-score ≤ -2) had a greater proportion of IgA+ bacteria in the fecal microbiota compared to non-stunted controls. This trend was consistent in both countries, despite the higher overall IgA-targeting of the microbiota in Madagascar, but lost significance in each country individually. Two of the most highly IgA-recognized bacteria regardless of nutritional status were Campylobacter (in CAR) and Haemophilus (in both countries), both of which were previously shown to be more abundant in stunted children; however, there was no association between IgA-targeting of these bacteria and either stunting or inflammatory markers. IgG-bound intestinal bacteria were rare in both stunted and non-stunted children, similar to levels observed in healthy populations. Undernourished children carry a high load of intestinal pathogens and pathobionts. Our data suggest that stunted children have a greater proportion of IgA-recognized fecal bacteria. We moreover identify two putative pathobionts, Haemophilus and Campylobacter, that are broadly targeted by intestinal IgA. This study furthers our understanding of host-microbiota interactions in undernutrition and identifies immune-recognized microbes for future study.

Sections du résumé

BACKGROUND
Child undernutrition is a global health issue that is associated with poor sanitation and an altered intestinal microbiota. Immunoglobulin (Ig) A mediates host-microbial homeostasis in the intestine, and acutely undernourished children have been shown to have altered IgA recognition of the fecal microbiota. We sought to determine whether chronic undernutrition (stunting) or intestinal inflammation were associated with antibody recognition of the microbiota using two geographically distinct populations from the Afribiota project. Fecal bacteria from 200 children between 2 and 5 years old in Antananarivo, Madagascar, and Bangui, Central African Republic (CAR), were sorted into IgA-positive (IgA+) and IgA-negative (IgA-) populations by flow cytometry and subsequently characterized by 16S rRNA gene sequencing to determine IgA-bacterial targeting. We additionally measured IgG+ fecal bacteria by flow cytometry in a subset of 75 children.
RESULTS
Stunted children (height-for-age z-score ≤ -2) had a greater proportion of IgA+ bacteria in the fecal microbiota compared to non-stunted controls. This trend was consistent in both countries, despite the higher overall IgA-targeting of the microbiota in Madagascar, but lost significance in each country individually. Two of the most highly IgA-recognized bacteria regardless of nutritional status were Campylobacter (in CAR) and Haemophilus (in both countries), both of which were previously shown to be more abundant in stunted children; however, there was no association between IgA-targeting of these bacteria and either stunting or inflammatory markers. IgG-bound intestinal bacteria were rare in both stunted and non-stunted children, similar to levels observed in healthy populations.
CONCLUSIONS
Undernourished children carry a high load of intestinal pathogens and pathobionts. Our data suggest that stunted children have a greater proportion of IgA-recognized fecal bacteria. We moreover identify two putative pathobionts, Haemophilus and Campylobacter, that are broadly targeted by intestinal IgA. This study furthers our understanding of host-microbiota interactions in undernutrition and identifies immune-recognized microbes for future study.

Identifiants

pubmed: 32718353
doi: 10.1186/s40168-020-00890-1
pii: 10.1186/s40168-020-00890-1
pmc: PMC7385872
doi:

Substances chimiques

Immunoglobulin A 0
Immunoglobulin G 0
RNA, Ribosomal, 16S 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113

Subventions

Organisme : CIHR
ID : FDN-159935
Pays : Canada

Investigateurs

Emilson Jean Andriatahirintsoa (EJ)
Alexandra Bastaraud (A)
Jean-Marc Collard (JM)
Maria Doria (M)
Serge Ghislain Djorie (SG)
Aurélie Etienne (A)
Brett Finlay (B)
Tamara Giles-Vernick (T)
Jean-Chrysostome Gody (JC)
Bolmbaye Privat Godje (BP)
Ionela Gouandjika-Vassilache (I)
Francis Allan Hunald (FA)
Nathalie Kapel (N)
Jean-Pierre Lombart (JP)
Alexandre Manirakiza (A)
Synthia Nazita Nigatoloum (SN)
Lisette Raharimalala (L)
Maheninasy Rakotondrainipiana (M)
Rindra Randremanana (R)
Harifetra Mamy Richard Randriamizao (HMR)
Frédérique Randrianirina (F)
Annick Robinson (A)
Pierre-Alain Rubbo (PA)
Philippe Sansonetti (P)
Laura Schaeffer (L)
Inès Vigan-Womas (I)
Sonia Sandrine Vondo (SS)
Pascale Vonaesch (P)
Laura Wegener-Parfrey (L)

Références

mSystems. 2019 Nov 26;4(6):
pubmed: 31771976
Clin Microbiol Rev. 2017 Oct;30(4):919-971
pubmed: 28768707
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Nature. 2016 May 25;534(7606):263-6
pubmed: 27279225
Pediatrics. 2016 Dec;138(6):
pubmed: 27940670
Immunity. 2018 Aug 21;49(2):211-224
pubmed: 30134201
Science. 2016 Jun 24;352(6293):1533
pubmed: 27339978
Cell. 2014 Aug 28;158(5):1000-1010
pubmed: 25171403
Clin Infect Dis. 2016 Nov 1;63(9):1171-1179
pubmed: 27501842
Sci Transl Med. 2017 Feb 8;9(376):
pubmed: 28179509
BMJ. 2007 Apr 7;334(7596):705-6
pubmed: 17413142
Appl Environ Microbiol. 2013 Sep;79(17):5112-20
pubmed: 23793624
J Immunol. 2015 Nov 1;195(9):4059-66
pubmed: 26477048
Am J Trop Med Hyg. 2013 Jul;89(1):130-137
pubmed: 23629931
J Allergy Clin Immunol. 2019 Apr;143(4):1575-1585.e4
pubmed: 30554723
Mucosal Immunol. 2020 Jan;13(1):3-11
pubmed: 31413347
EBioMedicine. 2017 Apr;18:109-117
pubmed: 28396264
Curr Opin Infect Dis. 2016 Jun;29(3):229-36
pubmed: 26967147
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
BMC Pediatr. 2018 Jul 19;18(1):236
pubmed: 30025542
Immunity. 2019 Apr 16;50(4):1099-1114.e10
pubmed: 30876876
Lancet. 2013 Aug 3;382(9890):427-451
pubmed: 23746772
Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S207-12
pubmed: 25305288
Microbiome. 2019 Jan 3;7(1):1
pubmed: 30606251
FEBS Lett. 2016 Nov;590(21):3840-3853
pubmed: 27508518
Clin Infect Dis. 2019 Sep 17;:
pubmed: 31773126
Pathog Glob Health. 2019 Mar;113(2):94-100
pubmed: 30879406
J Nutr. 2003 May;133(5):1332-8
pubmed: 12730419
Cell Host Microbe. 2020 Jun 10;27(6):909-921.e5
pubmed: 32289261
Sci Rep. 2018 Apr 11;8(1):5847
pubmed: 29643500
Matern Child Nutr. 2008 Apr;4 Suppl 1:24-85
pubmed: 18289157
Microbiome. 2015 Jun 13;3:24
pubmed: 26106478
Science. 2017 Oct 20;358(6361):359-365
pubmed: 29051379
PLoS Negl Trop Dis. 2018 Jan 19;12(1):e0006205
pubmed: 29351288
Nature. 2018 Oct;562(7728):583-588
pubmed: 30356187
Gut. 1996 Mar;38(3):365-75
pubmed: 8675088
J Pediatr Gastroenterol Nutr. 2016 Jul;63(1):6-14
pubmed: 26974416
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Cell Mol Gastroenterol Hepatol. 2019;7(3):692-707
pubmed: 30630118
Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3074-9
pubmed: 24569806
Nature. 2014 Jun 19;510(7505):417-21
pubmed: 24896187
Sci Transl Med. 2018 May 2;10(439):
pubmed: 29720448
J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):325-333
pubmed: 29356769
Gut Microbes. 2020 May 3;11(3):405-420
pubmed: 31203722
Sci Transl Med. 2015 Feb 25;7(276):276ra24
pubmed: 25717097
Paediatr Respir Rev. 2019 Nov;32:3-9
pubmed: 31422032
PLoS One. 2016 Sep 30;11(9):e0158772
pubmed: 27690129
J Bacteriol. 2010 Oct;192(19):5002-17
pubmed: 20656903
Sci Transl Med. 2019 Apr 3;11(486):
pubmed: 30944164
Cell. 2016 May 5;165(4):827-41
pubmed: 27153495
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Blood. 2012 Jun 14;119(24):5909-17
pubmed: 22555971
Lancet. 2008 Feb 2;371(9610):417-40
pubmed: 18206226
Cell Host Microbe. 2020 Feb 12;27(2):199-212.e5
pubmed: 32053789
Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):E8489-E8498
pubmed: 30126990

Auteurs

Kelsey E Huus (KE)

Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.
Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.

André Rodriguez-Pozo (A)

Unité de Pathogénie Microbienne Moléculaire, Institut Pasteur, Paris, France.

Nathalie Kapel (N)

Laboratoire de coprologie fonctionnelle, APHP.SU, Hôpital de la Pitié-Salpêtrière, Paris, France.

Alison Nestoret (A)

Laboratoire de coprologie fonctionnelle, APHP.SU, Hôpital de la Pitié-Salpêtrière, Paris, France.

Azimdine Habib (A)

Unité des Helminthiases, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Michel Dede (M)

Laboratoire d'Analyse médicale, Institut Pasteur de Bangui, Bangui, Central African Republic.

Amee Manges (A)

School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.

Jean-Marc Collard (JM)

Unité de Bactériologie Expérimentale, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Philippe J Sansonetti (PJ)

Unité de Pathogénie Microbienne Moléculaire, Institut Pasteur, Paris, France.
Current address: Center for Microbes, Development and Health, Institut Pasteur de Shanghai, Shanghai, China.

Pascale Vonaesch (P)

Unité de Pathogénie Microbienne Moléculaire, Institut Pasteur, Paris, France.
Current address: Human and Animal Health Unit, Swiss Tropical and Public Health Institute & University of Basel, Basel, Switzerland.

B Brett Finlay (BB)

Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada. bfinlay@msl.ubc.ca.
Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada. bfinlay@msl.ubc.ca.
Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada. bfinlay@msl.ubc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH